LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
13.49
-0.03 (-0.22%)
At close: Feb 27, 2026, 4:00 PM EST
13.23
-0.26 (-1.93%)
After-hours: Feb 27, 2026, 7:53 PM EST
LENZ Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for LENZ Therapeutics stock have an average target of 56.25, with a low estimate of 50 and a high estimate of 67. The average target predicts an increase of 316.98% from the current stock price of 13.49.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 20, 2025.
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Reiterates $40 → $50 | Buy | Reiterates | $40 → $50 | +270.64% | Oct 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 → $67 | Buy | Maintains | $51 → $67 | +396.66% | Oct 10, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $49 → $52 | Strong Buy | Maintains | $49 → $52 | +285.47% | Aug 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $56 | Strong Buy | Maintains | $48 → $56 | +315.12% | Aug 1, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $49 | Strong Buy | Maintains | $45 → $49 | +263.23% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
19.50M
Revenue Next Year
50.16M
from 19.50M
Increased by 157.21%
EPS This Year
-2.70
from -2.34
EPS Next Year
-3.01
from -2.70
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 22.7M | 63.6M | ||||
| Avg | 19.5M | 50.2M | ||||
| Low | 17.2M | 39.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 226.2% | ||||
| Avg | - | 157.2% | ||||
| Low | - | 103.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.57 | -2.09 | ||||
| Avg | -2.70 | -3.01 | ||||
| Low | -2.68 | -4.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.